Insiders Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Market Closed - Australian S.E. Other stock markets 07:10:14 28/06/2024 BST			5-day change	1st Jan Change
4.71 ^AUD	+1.51%		+2.17%	-23.41%

06-03	Swissmedic Grants Mayne Pharma Group Expanded Kapanol Dosage Approvals in Switzerland	MT
05-24	Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mayne Pharma Group Limited Approves Election of Anne Lockwood	11-30	CI
Mayne Pharma Group Limited Announces Retirement of Carolyn Myers from the Board At the End of July 2023	27/07/23	CI
Services Data and Factory Orders Anticipation Drag Exchange-Traded Funds, Stock Futures Lower	05/12/22	MT
Mayne Pharma Group Limited Announces Executive Changes Effective from 1 October 2022	28/09/22	CI
Mayne Pharma Group Limited Appoints Mr. Shawn Patrick O'brien as Chief Executive Officer	28/09/22	CI
Mayne Pharma Group Limited Announces Management Changes	30/08/22	CI
Mayne Pharma Group CEO to Retire	19/08/22	MT
Scott Richards Plans to Retire as CEO of Mayne Pharma Group Limited	18/08/22	CI
Mayne Pharma Names New CFO; Shares Jump 5%	22/07/22	MT
Ann Custin Accepts to Join the Board and Audit and Risk Committee of Mayne Pharma Group Limited	21/03/22	CI
Mayne Pharma Group Limited Announces Management Changes	16/01/22	CI
Mayne Pharma Group Limited Appoints Carolyn Myers to the Board	03/10/21	CI
Mayne Pharma Group Limited Announces Board Changes	26/08/21	CI
Mayne Pharma Group Limited Appoints Peter Paltoglou as Chief Financial Officer	28/09/20	CI
Mayne Pharma : Toni Nesci named head of Mayne Contract Services and New Website Launched	03/06/20	AQ
Mayne Pharma Group Limited Announces Executive Changes	19/03/20	CI
Mayne Pharma Group Limited Announces the Cessation of Ron Best as Director Effective from 22 November 2019	24/11/19	CI
Mayne Pharma Group Limited Announces Retirement of Ron Best as Non-Executive Director	21/10/19	CI
Mayne Pharma Group Limited Announces FDA Approves Trade Name Lexette(TM) (halobetasol propionate) Foam, 0.05%	30/04/19	CI
Phil Hodges Announces to Retire as Director of Mayne Pharma Group Limited	29/10/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Mayne Pharma Group Limited

Equities

MYX

AU000000MYX0

Insiders

Filters